Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × CNS × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 26 Genitourinary 11 Other hematologic neoplasm 6 Breast 6 Gynecologic 5 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Brain Neoplasms 2293 Glioblastoma 1990 Glioma 1386 Central Nervous System Neoplasms 689 Astrocytoma 664 Neuroblastoma 644 Gliosarcoma 478 Oligodendroglioma 404 Neoplasms 401 Breast Neoplasms 324 Medulloblastoma 305 Carcinoma, Non-Small-Cell Lung 252 Meningioma 226 Recurrence 220 Sarcoma 213 Melanoma 205 Neoplasm Metastasis 201 Lung Neoplasms 197 Ependymoma 196 Neurofibromatosis 1 168 Lymphoma 160 Meningeal Carcinomatosis 137 Osteosarcoma 134 Ovarian Neoplasms 131 Precursor Cell Lymphoblastic Leukemia-Lymphoma 123 Wilms Tumor 122 Lymphoma, Non-Hodgkin 116 Head and Neck Neoplasms 114 Diffuse Intrinsic Pontine Glioma 111 Rhabdomyosarcoma 105

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02530749 2019-07-11

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

University of Colorado, Denver

Frailty, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡